Glenmark Pharmaceuticals Ltd. - Research Center

---

(Rs crore)

Half yearly results in brief

	Sep ' 09	Mar ' 09	Sep ' 08	Mar ' 08	Sep ' 07
Sales	456.20	435.93	420.00	822.49	550.20
Operating profit	69.21	98.47	123.29	310.40	171.31
Interest	9.40	29.72	25.42	20.91	20.22
Gross profit	64.31	141.82	123.66	306.77	153.87
EPS (Rs)	2.33	3.76	4.94	11.12	4.61

	Sep ' 09	Mar ' 09	Sep ' 08	Mar ' 08	Sep ' 07
Other income	4.49	73.07	25.79	17.27	2.78
Stock adjustment	-11.22	-9.12	-6.04	-12.44	-17.76
Raw material	109.01	102.26	70.63	240.15	163.19
Power and fuel	-	-	-	-	-
Employee expenses	60.33	63.60	66.23	67.27	61.94
Excise	-	-	-	-7.99	7.99
Admin and selling expenses	-	-	-	-76.62	76.62
Research and development expenses	-	-	-	-	-
Expenses capitalised	-	-	-	-	-
Other expenses	228.86	180.72	165.89	301.71	86.92
Provisions made	-	-	-	-	-
Depreciation	10.58	10.17	8.93	15.95	13.50
Taxation	-9.00	37.44	-9.30	14.25	27.91
Net profit / loss	62.72	94.20	123.72	276.57	112.46
Extra ordinary item	-	-	-0.30	-	-
Prior year adjustments	-	-	-	-	-
Equity capital	26.96	25.05	25.02	24.87	24.39
Equity dividend rate	-	-	-	-	-
Agg.of non-prom. shares (Lacs)	1390.86	1200.24	1197.83	1183.67	1135.78
Agg.of non promotoholding (%)	51.59	47.91	47.88	47.59	46.56
OPM (%)	15.17	22.59	29.36	37.74	31.14
GPM (%)	13.96	27.86	27.74	36.53	27.82
NPM (%)	13.61	18.51	27.75	32.93	20.34

© Copyright 2009 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback